FDA To Consider Patient Input For Benefit-Risk Decisions For IDEs
This article was originally published in The Gray Sheet
Executive Summary
The agency will take into account patient preferences when making benefit-risk determinations for investigational device exemptions, according to a June 18 draft guidance.